3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Neoplasms
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
blinatumomab
2
venetoclax
1
osimertinib
1
Vincristine
1
Transplantation
1
Sorafenib
1
Radiotherapy
1
Oxaliplatin
1
Neoadjuvant Therapy
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methotrexate
1
Maintenance
1
Liquid Biopsy
1
Leucovorin
1
Irinotecan
1
Hematologic Tests
1
Fluorouracil
1
Dexamethasone
1
Cytarabine
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Blood Specimen Collection
1
BEBT-908
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasm, Residual
×
Maintenance
×
Clear all
NCT07572929
2026-05-07
PREeMPT
Medical College of Wisconsin
Phase 2
Not yet recruiting
450 enrolled